INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2006

Coffee intake was linked to higher nonfatal myocardial infarction risk only among individuals who were slow caffeine metabolizers.

A case-control study assessed whether CYP1A2 genotype modified the link between caffeinated coffee consumption and first acute nonfatal myocardial infarction (MI) in Costa Rica. Among carriers of the slow *1F allele, multivariate-adjusted ORs (95% CIs) for nonfatal MI across <1, 1, 2-3, and >=4 cups of coffee per day were 1.00 (reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83), and 1.64 (1.14-2.34). In contrast, corresponding ORs for rapid *1A/*1A individuals were 1.00, 0.75 (0.51-1.12), 0.78 (0.56-1.09), and 0.99 (0.66-1.48) (P = .04 for interaction). Among participants younger than 59 years, >=4 cups/day had an OR of 2.33 (1.39-3.89) in slow metabolizers, whereas rapid metabolizers had lower risks with 1 and 2-3 cups/day.

Shows an association, not proof of cause and effect.

Study type
Case-control study
Who was studied
2,014 cases with first acute nonfatal MI and 2,014 matched population controls in Costa Rica
What was measured
Relative risk of nonfatal myocardial infarction associated with coffee intake

THE PAPER

Coffee, CYP1A2 genotype, and risk of myocardial infarction.

Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. JAMA, 2006.

PubMed 16522833 ↗DOI 10.1001/jama.295.10.1135 ↗

Heart & arteries

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.